Health Care Stocks Held by Hedge Funds
All health care-sector stocks held by tracked institutional funds per the latest SEC 13F filings, sorted by number of fund holders.
ALLO
Allogene Therapeutics
0.67
-4.17%
143Funds Holding
$318.85MInstitutional value
-71vs last quarter
LEGN
Legend Biotech
16.10
-0.92%
143Funds Holding
$1.01BInstitutional value
-82vs last quarter
CDRE
Cadre Holdings
30.56
-4.14%
142Funds Holding
$608.66MInstitutional value
-21vs last quarter
ESTA
Establishment Labs Holdings
69.61
-1.68%
141Funds Holding
$1.04BInstitutional value
-68vs last quarter
ALT
Altimmune
1.41
+1.44%
140Funds Holding
$248.70MInstitutional value
-82vs last quarter
ALMS
Alumis
4.33
-1.48%
139Funds Holding
$297.46MInstitutional value
-73vs last quarter
SGRY
Surgery Partners
26.69
-1.00%
139Funds Holding
$663.78MInstitutional value
-60vs last quarter
CERS
Cerus
1.90
-2.06%
138Funds Holding
$286.24MInstitutional value
-56vs last quarter
EBS
Emergent Biosolutions
5.15
-6.36%
138Funds Holding
$219.59MInstitutional value
-67vs last quarter
ELVN
Enliven Therapeutics
46.41
+3.39%
138Funds Holding
$1.88BInstitutional value
-84vs last quarter
SPRY
Ars Pharmaceuticals
3.36
-8.94%
138Funds Holding
$189.56MInstitutional value
-78vs last quarter
TSHA
Taysha Gene Therapies
3.77
-5.51%
138Funds Holding
$698.95MInstitutional value
-78vs last quarter
ANNX
Annexon
3.41
-3.12%
137Funds Holding
$445.04MInstitutional value
-87vs last quarter
AGL
Agilon Health
89.50
-1.14%
136Funds Holding
$1.07BInstitutional value
-49vs last quarter
ZVRA
Zevra Therapeutics
9.07
-2.26%
136Funds Holding
$411.89MInstitutional value
-34vs last quarter
DNA
Ginkgo Bioworks Holdings
8.20
-2.84%
135Funds Holding
$375.54MInstitutional value
-59vs last quarter
PRTA
Prothena
8.40
+0.60%
135Funds Holding
$247.29MInstitutional value
-62vs last quarter
ACB
Aurora Cannabis
4.26
-3.18%
134Funds Holding
$15.41MInstitutional value
-23vs last quarter
PSNL
Personalis
14.72
-1.74%
134Funds Holding
$1.03BInstitutional value
-32vs last quarter
MBX
Mbx Biosciences
53.41
-0.02%
133Funds Holding
$1.67BInstitutional value
-48vs last quarter
PRME
Prime Medicine
3.84
+0.52%
133Funds Holding
$235.11MInstitutional value
-64vs last quarter
SIBN
Si-Bone
23.75
+0.89%
133Funds Holding
$500.44MInstitutional value
-44vs last quarter
CTMX
Cytomx Therapeutics
2.05
+9.04%
132Funds Holding
$317.03MInstitutional value
-52vs last quarter
MGTX
Meiragtx Holdings
8.14
-2.16%
132Funds Holding
$461.09MInstitutional value
-32vs last quarter
AVXL
Anavex Life Sciences
0.67
-7.21%
131Funds Holding
$61.05MInstitutional value
-59vs last quarter
OMDA
Omada Health
12.50
-5.09%
131Funds Holding
$888.91MInstitutional value
-31vs last quarter
VNDA
Vanda Pharmaceuticals
3.67
-2.13%
131Funds Holding
$561.56MInstitutional value
-49vs last quarter
BVS
Bioventus
9.95
-6.31%
130Funds Holding
$596.68MInstitutional value
-36vs last quarter
MYGN
Myriad Genetics
5.54
+0.18%
130Funds Holding
$284.13MInstitutional value
-75vs last quarter
RIGL
Rigel Pharmaceuticals
41.19
-3.15%
130Funds Holding
$547.98MInstitutional value
-34vs last quarter
ANGO
Angiodynamics
10.76
-4.95%
129Funds Holding
$390.42MInstitutional value
-43vs last quarter
BLLN
Billiontoone Inc Cl A
90.20
-1.46%
129Funds Holding
$1.42BInstitutional value
-38vs last quarter
GLUE
Monte Rosa Therapeutics
8.91
-1.76%
129Funds Holding
$508.27MInstitutional value
-75vs last quarter
GRFS
Grifols S A
8.20
-3.19%
129Funds Holding
$586.52MInstitutional value
-42vs last quarter
PBYI
Puma Biotechnology
7.12
-1.39%
129Funds Holding
$280.83MInstitutional value
-38vs last quarter
SRTA
Strata Critical Medical
4.83
-2.62%
129Funds Holding
$241.32MInstitutional value
-21vs last quarter
CGEM
Cullinan Therapeutics
9.07
+0.67%
128Funds Holding
$475.19MInstitutional value
-61vs last quarter
ORIC
Oric Pharmaceuticals
7.70
+0.65%
128Funds Holding
$733.54MInstitutional value
-59vs last quarter
NAMS
Newamsterdam Pharmaceuticals
19.51
-1.17%
127Funds Holding
$1.54BInstitutional value
-83vs last quarter
OLMA
Olema Pharmaceuticals
7.15
+1.27%
127Funds Holding
$448.94MInstitutional value
-61vs last quarter
CRVS
Corvus Pharmaceuticals
10.01
-1.77%
125Funds Holding
$426.72MInstitutional value
-54vs last quarter
HRTX
Heron Therapeutics
0.26
-3.26%
125Funds Holding
$16.32MInstitutional value
-44vs last quarter
STOK
Stoke Therapeutics
26.93
+0.90%
125Funds Holding
$1.03BInstitutional value
-79vs last quarter
CMPX
Compass Therapeutics
0.68
+11.05%
124Funds Holding
$73.85MInstitutional value
-100vs last quarter
OABI
Omniab
5.03
-0.98%
124Funds Holding
$192.04MInstitutional value
-15vs last quarter
RGNX
Regenxbio
7.18
-1.10%
124Funds Holding
$287.11MInstitutional value
-52vs last quarter
TRAX
First Tracks Biotherapeutics
44.46
-0.09%
124Funds Holding
$596.74MInstitutional value
-31vs last quarter
EOLS
Evolus
7.00
-0.99%
123Funds Holding
$241.13MInstitutional value
-45vs last quarter
TCMD
Tactile Sys Technology
25.99
-1.63%
123Funds Holding
$336.14MInstitutional value
-65vs last quarter
AKBA
Akebia Therapeutics
0.42
+3.28%
122Funds Holding
$70.32MInstitutional value
-55vs last quarter
1036 stocks in Health Care · prices as of 2026-11-19